IDH2 and acute myeloid leukemia: Eleven studies including 12,725 AML patients were included in the meta-analysis, of which 1,416 (11.1%) patients had IDH2 mutations, while IDH2R140 and IDH2R172 mutations were found in 1,111 (8.7%) and 305 (2.4%) AML patients, respectively.